Caris Life Sciences (CAI) shares rose 33% in their debut Wednesday on Nasdaq following the company's initial public offering of 23.5 million shares priced at $21 each.
The stock traded at $27.86 around midday after opening at $27 and rising as high as $29.40.
The company granted underwriters an option to buy up to an additional 3.53 million shares at the IPO price.
The IPO is expected to close Friday.
Price: 27.86, Change: +6.86, Percent Change: +32.52
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.